Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclical vs Daily PTH with Alendronate in Osteoporosis
NCT00005006Phase 2Completed
- Sponsor
- Helen Hayes Hospital
- Start
- Sep 1987
- Primary completion
- Feb 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of teriparatide in osteoporosis (3 arms), sponsored by Helen Hayes Hospital. Primary endpoints: Bone Mineral Density at 18 months, Biochemical markers of bone formation at 18 months and 1 more. Started Sep 1987; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00005006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005006.